Medical Imaging Corp. (MEDD)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Medical Imaging Corp. (MEDD) trades at $0.00. Medical Imaging Corp. provides medical diagnostic imaging services to patients, hospitals, clinics, workers' compensation boards, and insurance companies. Market cap: $3,191, Sector: Healthcare.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for MEDD: MEDD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MEDD against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
MEDD: 1/1 perspectives are bearish.
How is this calculated? →Medical Imaging Corp. (MEDD) Healthcare & Pipeline Overview
Medical Imaging Corp. delivers diagnostic imaging services, including MRI, CT, and ultrasound, primarily in North America. Operating diagnostic centers and offering remote reading services, the company caters to patients, hospitals, and insurance providers. With a negative profit margin and OTC market listing, MEDD faces significant financial and market challenges.
What Is the Investment Thesis for MEDD?
Medical Imaging Corp. operates in the diagnostic imaging services sector, facing both opportunities and challenges. The company's comprehensive range of imaging modalities and services, including remote reading and reporting, positions it to serve a broad client base. However, its negative profit margin of -41.8% and lack of dividend payments raise concerns about financial sustainability. Trading on the OTC market introduces additional risks related to liquidity and regulatory oversight. Growth catalysts could include expanding its geographic footprint and forming strategic partnerships with hospitals and clinics. Investors should carefully consider the company's financial performance, market position, and OTC listing before making investment decisions. The high beta of 6.12 indicates high volatility.
Based on FMP financials and quantitative analysis
MEDD Key Highlights
- Market capitalization of 3K indicates a micro-cap company with limited financial resources.
- Negative P/E ratio of -0.00 reflects the company's lack of profitability.
- Profit margin of -41.8% suggests significant operational inefficiencies and cost management challenges.
- Gross margin of 15.1% indicates a limited ability to generate profit from its services after accounting for direct costs.
- Beta of 6.12 suggests the stock is significantly more volatile than the market.
Who Are MEDD's Competitors?
MEDD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| PRE Prenetics Global Limited | $17.25 | +1.88% | $293.23M | 69 |
| EPGNY Epigenomics AG | $2.39 | +0.00% | 68 | |
| STRRP Star Equity Holdings, Inc. | $9.89 | -0.10% | $40.58M | 68 |
| TWST Twist Bioscience Corporation | $100.97 | +1.74% | $6.29B | 65 |
| CNTG Centogene N.V. | $0.33 | +100.00% | $9.42M | 50 |
| NVTA Invitae Corporation | $0.02 | -35.59% | $5.44M | 50 |
| ICLR ICON Public Limited Company | $170.94 | -1.23% | $13.09B | 50 |
| ME 23andMe Holding Co. | $0.61 | +100.00% | $15.31M | 50 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MEDD's Key Strengths?
- Comprehensive range of diagnostic imaging services.
- Remote reading and reporting capabilities.
- Established relationships with hospitals and clinics.
- Experience in serving workers' compensation boards and insurance companies.
What Are MEDD's Weaknesses?
- Negative profit margin.
- Limited market capitalization.
- OTC market listing.
- Dependence on a small number of diagnostic centers.
What Could Drive MEDD Stock Higher?
- Potential partnerships with hospitals and clinics to expand service offerings by Q4 2026.
- Efforts to enhance teleradiology capabilities to reach a broader geographic area, with continuous technology upgrades planned throughout 2026.
- Investment in advanced imaging technologies, such as AI-powered diagnostic tools, to improve accuracy and efficiency, with pilot programs starting in Q2 2026.
What Are the Key Risks for MEDD?
- Negative profit margin of -41.8% raises concerns about financial sustainability and the ability to fund future growth.
- Intense competition in the diagnostic imaging market may limit the company's ability to gain market share and maintain pricing.
- Regulatory changes and reimbursement policies could negatively impact revenue and profitability.
- OTC market listing introduces risks related to liquidity, transparency, and regulatory oversight.
- Technological obsolescence could render the company's imaging equipment and services outdated.
What Are the Growth Opportunities for MEDD?
- Expansion of Teleradiology Services: The increasing demand for remote diagnostic imaging services presents a significant growth opportunity for Medical Imaging Corp. By expanding its teleradiology capabilities, the company can reach a broader geographic area and serve more patients. The global teleradiology market is projected to reach $12 billion by 2028, offering a substantial market for growth. This expansion requires investment in technology infrastructure and skilled radiologists.
- Strategic Partnerships with Hospitals and Clinics: Forming strategic partnerships with hospitals and clinics can provide Medical Imaging Corp. with a steady stream of patient referrals and access to new markets. These partnerships can involve providing on-site imaging services or offering remote reading services. Collaborations can enhance the company's market presence and revenue generation. Successful partnerships require careful negotiation and alignment of goals.
- Adoption of Advanced Imaging Technologies: Investing in advanced imaging technologies, such as AI-powered diagnostic tools, can improve the accuracy and efficiency of Medical Imaging Corp.'s services. These technologies can enhance the company's competitive advantage and attract new clients. The market for AI in medical imaging is expected to grow significantly in the coming years, driven by the need for faster and more accurate diagnoses. Implementation requires capital investment and staff training.
- Focus on Specialized Imaging Services: Specializing in specific imaging services, such as cardiac imaging or oncology imaging, can allow Medical Imaging Corp. to differentiate itself from competitors and attract a niche market. These specialized services require expertise and advanced equipment. Focusing on high-demand specialties can improve profitability and market positioning. This strategy demands targeted marketing and specialized training programs.
- Geographic Expansion within North America: Expanding its geographic footprint within North America can enable Medical Imaging Corp. to reach new patient populations and increase its revenue base. This expansion can involve establishing new diagnostic centers or acquiring existing imaging facilities. Careful market research and strategic planning are essential for successful geographic expansion. This growth driver necessitates capital investment and operational expertise.
What Opportunities Does MEDD Have?
- Expansion of teleradiology services.
- Strategic partnerships with hospitals and clinics.
- Adoption of advanced imaging technologies.
- Geographic expansion within North America.
What Threats Does MEDD Face?
- Intense competition in the diagnostic imaging market.
- Regulatory changes and reimbursement policies.
- Technological obsolescence.
- Economic downturn impacting healthcare spending.
What Are MEDD's Competitive Advantages?
- Established relationships with hospitals and clinics.
- Comprehensive range of imaging modalities.
- Remote reading and reporting capabilities.
- Experience in serving workers' compensation boards and insurance companies.
What Does MEDD Do?
Medical Imaging Corp., formerly known as Diagnostic Imaging International Corp., was founded in 2000 and rebranded in July 2014. Headquartered in Las Vegas, Nevada, the company focuses on providing medical diagnostic imaging services. These services include remote reading and reporting of medical diagnostic imaging scans, catering to a diverse clientele including patients, hospitals, clinics, workers' compensation boards, and insurance companies across North America. The company offers a comprehensive suite of imaging modalities, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), ultrasound, nuclear medicine, digital mammography, X-ray, and bone mineral densitometry. As of December 31, 2017, Medical Imaging Corp. operated an independent diagnostic imaging facility in Pottsville, Pennsylvania, and three diagnostic centers in Florida. The company's business model centers on delivering timely and accurate diagnostic imaging services, bridging the gap between imaging technology and patient care. However, the company faces challenges, including a negative profit margin and trading on the OTC market, which may impact its growth and stability.
What Products and Services Does MEDD Offer?
- Provides remote reading and reporting of medical diagnostic imaging scans.
- Offers magnetic resonance imaging (MRI) services.
- Provides computed tomography (CT) services.
- Offers positron emission tomography (PET) services.
- Provides ultrasound services.
- Offers nuclear medicine services.
- Provides digital mammography services.
- Offers X-ray services.
- Provides bone mineral densitometry modalities.
How Does MEDD Make Money?
- Provides diagnostic imaging services to patients, hospitals, and clinics.
- Generates revenue through fees for imaging scans and reporting services.
- Contracts with workers' compensation boards and insurance companies for imaging services.
- Operates diagnostic imaging facilities and centers.
What Industry Does MEDD Operate In?
Medical Imaging Corp. operates within the medical diagnostics and research industry, a sector experiencing growth driven by technological advancements and an aging population. The market is competitive, with established players and smaller firms vying for market share. Key trends include the increasing adoption of advanced imaging technologies, the rise of teleradiology, and the growing demand for diagnostic services. Medical Imaging Corp. competes with companies offering similar imaging services, facing pressure to innovate and maintain competitive pricing. The industry is also subject to regulatory oversight and reimbursement policies, impacting profitability and market access.
Who Are MEDD's Key Customers?
- Patients requiring diagnostic imaging services.
- Hospitals and clinics seeking outsourced imaging services.
- Workers' compensation boards requiring imaging for injured workers.
- Insurance companies needing imaging for claims processing.
Company Profile
Medical Imaging Corp. operates in the Medical - Diagnostics & Research industry within the Healthcare sector. It is headquartered in Las Vegas, US. The company is led by CEO Mitchell Geisler. MEDD has traded publicly since 2008.
How Medical Imaging Corp. Is Valued
Medical Imaging Corp. carries a market capitalization of 3K, placing it in the micro-cap category.
ROE 74%Key Financial Metrics
Return on equity for Medical Imaging Corp. stands at 73.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -72.1%, showing how much profit it generates from its asset base. A current ratio of 0.13 means current liabilities exceed short-term assets, a liquidity point worth watching.
MEDD Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Comprehensive range of diagnostic imaging services.
- Remote reading and reporting capabilities.
- Established relationships with hospitals and clinics.
- Experience in serving workers' compensation boards and insurance companies.
Bear Case
- Negative profit margin.
- Limited market capitalization.
- OTC market listing.
- Dependence on a small number of diagnostic centers.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
MEDD Latest News
No recent news available for MEDD.
MEDD Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MEDD.
Price Targets
Wall Street price target analysis for MEDD.
MEDD MoonshotScore
What does this score mean?
The MoonshotScore rates MEDD's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Mitchell Geisler
CEO
Mitchell Geisler serves as the CEO of Medical Imaging Corp., overseeing the company's strategic direction and operations. His background includes experience in managing teams and implementing growth strategies. He is responsible for guiding the company's efforts in providing diagnostic imaging services and expanding its market presence. Geisler's leadership is focused on driving innovation and improving patient outcomes through advanced imaging technologies.
Track Record: Under Mitchell Geisler's leadership, Medical Imaging Corp. has focused on maintaining its existing diagnostic centers and exploring opportunities for expansion. Key milestones include efforts to enhance the company's teleradiology capabilities and strengthen relationships with hospitals and clinics. Geisler has also emphasized the importance of investing in advanced imaging technologies to improve the accuracy and efficiency of diagnostic services.
MEDD OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Medical Imaging Corp. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial information available and may be subject to greater risks. Trading on the OTC Other tier typically involves less stringent listing requirements compared to major exchanges like the NYSE or NASDAQ, resulting in reduced transparency and investor protection.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in Medical Imaging Corp.
- Low trading volume and liquidity can lead to significant price volatility.
- OTC Other tier listing indicates a higher risk of fraud or mismanagement.
- Lack of regulatory oversight compared to major exchanges.
- Potential for delisting or trading suspension due to non-compliance.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's revenue and profitability trends.
- Check for any legal or regulatory issues.
- Monitor news and press releases for any significant developments.
- Consult with a financial advisor before investing.
- Company has been in operation since 2000.
- Provides essential diagnostic imaging services.
- Operates diagnostic facilities in multiple states.
- CEO is identified and managing the company.
- Company has a history of providing services to patients, hospitals, and insurance companies.
MEDD Healthcare Stock FAQ
What does Medical Imaging Corp. do?
Medical Imaging Corp. provides a range of diagnostic imaging services, including MRI, CT scans, and X-rays, to patients, hospitals, and clinics. The company focuses on remote reading and reporting of medical diagnostic imaging scans, offering a comprehensive suite of modalities. Operating diagnostic facilities and partnering with healthcare providers, Medical Imaging Corp. aims to deliver timely and accurate diagnostic information to support patient care and treatment decisions. The company serves a diverse clientele, including workers' compensation boards and insurance companies.
What do analysts say about MEDD stock?
As of March 18, 2026, there is no readily available analyst coverage or consensus on Medical Imaging Corp. (MEDD) due to its OTC listing and limited market capitalization. Key valuation metrics, such as P/E ratio (-0.00) and profit margin (-41.8%), reflect the company's current financial challenges. Growth considerations include the potential for expanding teleradiology services and forming strategic partnerships. Investors should conduct thorough due diligence and consider the risks associated with OTC-listed stocks before making any investment decisions.
What are the main risks for MEDD?
Medical Imaging Corp. faces several risks, including its negative profit margin, which indicates financial instability. The company's OTC market listing introduces liquidity and regulatory risks. Intense competition in the diagnostic imaging market could pressure pricing and market share. Regulatory changes and reimbursement policies may impact revenue. Additionally, technological advancements could render existing equipment obsolete, requiring significant capital investments. Investors should carefully consider these risks before investing in MEDD.
What are the key factors to evaluate for MEDD?
Evaluate MEDD on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does MEDD data refresh on this page?
MEDD prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven MEDD's recent stock price performance?
Medical Imaging Corp. (MEDD) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive range of diagnostic imaging services. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MEDD overvalued or undervalued right now?
Valuing Medical Imaging Corp. (MEDD) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying MEDD?
Before investing in Medical Imaging Corp. (MEDD), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited to information available as of December 31, 2017.
- OTC market data may be less reliable than data from major exchanges.
- AI analysis is pending and may provide additional insights.